The importance of ERK1/2 activation by the microenvironment is underscored by studies showing that inhibitors of MEK1/2, such as MEKi-1, which block ERK1/2 activation, can abrogate the survival signaling provided to leukemia cells by the microenvironment [8]. Here, MAPK3 is linked to leukemia.